Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients

Characterization, diagnosis, and treatment of colorectal cancers (CRC) is difficult due to limited biopsy information, impracticality of repeated biopsies, and cancer biomarker fallibility. Circulating tumor DNA (ctDNA) has recently been investigated as a non-invasive way to gain representative gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying-Chi, Wang, Dong, Jin, Lan, Yao, Hong-Wei, Zhang, Jing-Hui, Wang, Jin, Zhao, Xiao-Mu, Shen, Chun-Ying, Chen, Wei, Wang, Xue-Liang, Shi, Rong, Chen, Si-Yi, Zhang, Zhong-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066652/
https://www.ncbi.nlm.nih.gov/pubmed/29914973
http://dx.doi.org/10.1042/BSR20180322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066652/
https://www.ncbi.nlm.nih.gov/pubmed/29914973
http://dx.doi.org/10.1042/BSR20180322

Ejemplares similares